Atracurium

DB13295ApprovedInvestigationalWithdrawnSmall moleculeNeuromuscular-Blocking Agents (Nondepolarizing)

Atracurium is a neuromuscular blocker indicated to relax muscles during mechanical ventilation under general anesthesia or intubation. A medication used to make it easier to insert a breathing tube in patients during surgery.

Resolves to

Compound

UNII2GQ1IRY63PCAS64228-79-1

Clinical / RWD

RxNorm1218ATCM03AC04

Targets

P36544CHRNA7Q96LB1MRGPRX2

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1,120Drug interactionsStructured to mechanism, not free text

56Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

2ContraindicationsEach with its own population and attribute set

12Marketed productsAcross 4 countries and 7 labellers

1ATC codeIncluding every combination product, plus 17 drug categories

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Atracurium, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account